These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 708469)

  • 1. Complement inhibition by amidines and guanidines--in vivo and in vitro results.
    Otterness IG; Torchia AJ; Doshan HD
    Biochem Pharmacol; 1978; 27(14):1873-8. PubMed ID: 708469
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR; Erickson EH
    J Med Chem; 1969 May; 12(3):408-14. PubMed ID: 5788155
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of various immunological reactions in vivo by a new synthetic complement inhibitor.
    Hitomi Y; Fujii S
    Int Arch Allergy Appl Immunol; 1982; 69(3):262-7. PubMed ID: 6215361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on 6-amidino-2-naphthyl[4-(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethane sulfonate (FUT-187). I: Inhibitory activities on various kinds of enzymes in vitro and anticomplement activity in vivo.
    Oda M; Ino Y; Nakamura K; Kuramoto S; Shimamura K; Iwaki M; Fujii S
    Jpn J Pharmacol; 1990 Jan; 52(1):23-34. PubMed ID: 1689782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacological approach to Forssman shock.
    Nagai H; Kurimoto Y; Koda A
    Microbiol Immunol; 1980; 24(7):649-55. PubMed ID: 7412598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. No additional effect of cyclosporine.
    Scheringa M; Schraa EO; Bouwman E; van Dijk H; Melief MJ; Ijzermans JN; Marquet RL
    Transplantation; 1995 Dec; 60(11):1350-3. PubMed ID: 8525534
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
    Baker BR; Cory M
    J Med Chem; 1969 Nov; 12(6):1049-52. PubMed ID: 5389146
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
    Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
    Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
    Hauptmann J; Markwardt F
    Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
    Bing DH
    J Immunol; 1970 Nov; 105(5):1289-91. PubMed ID: 5489072
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM; Cory M; Alenty A
    Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of the classical pathway of human complement by polymyxin B.
    Asghar SS; Boot T; van der Helm HJ
    Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant activity of aliphatic nitrogenous bases.
    Gall D
    Immunology; 1966 Oct; 11(4):369-86. PubMed ID: 5924622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of synthalin A on the islands of Langerhans in guinea pigs].
    RUNGE W
    Klin Wochenschr; 1954 Aug; 32(31-32):748-9. PubMed ID: 13202402
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate.
    Nakayama T; Taira S; Ikeda M; Ashizawa H; Oda M; Arakawa K; Fujii S
    Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):117-25. PubMed ID: 8448813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in immunochemistry. 2. Inhibition of complement by benzamidines.
    Hansch C; Yoshimoto M
    J Med Chem; 1974 Nov; 17(11):1160-7. PubMed ID: 4415920
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiotoxicity of Forssman antibodies in in vitro perfusion experiments.
    Chen H; Diakun KR; Milgrom F
    Immunol Commun; 1984; 13(6):571-6. PubMed ID: 6335882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the first component of human complement by m-(o-(2-chloro-5-fluorosulfonylphenylureido)-phenoxybutoxy)benzamidine.
    Bing DH; Mernitz JL; Spurlock SE
    Biochemistry; 1972 Nov; 11(23):4263-8. PubMed ID: 4673057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increase in pulmonary resistance induced by Forssman antiserum in guinea pigs].
    Nakagami K; Kobayashi T; Takayanagi N; Yano J; Miura M
    Nihon Yakurigaku Zasshi; 1983 Dec; 82(6):429-41. PubMed ID: 6607868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
    Hoffmann A; Markwardt F
    Pharmazie; 1989 Feb; 44(2):141-4. PubMed ID: 2748697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.